Michael Korenjak
Scientist-Molecular Biologist
Epigenomics and Mechanisms
Speciality: Molecular Biology
| Year | Degree | Major | Institution | Country/Town |
|---|---|---|---|---|
| 2007 | PhD | Molecular Biology | University of Munich (LMU) | Germany / Munich |
| 2002 | MSc | Microbiology | University of Innsbruck | Austria / Innsbruck |
Current Research Projects
Analysis of the mutual relationship between carcinogen-exposure and chromatin structure
In vitro models of carcinogen exposure
Selected Publications
Hölzl-Armstrong L, Kucab JE, Korenjak M, Luijten M, Phillips DH, Zavadil J, Arlt VM. Characterising Mutational Spectra of Carcinogens in the Tumour Suppressor Gene TP53 Using Human TP53 Knock-in (Hupki) Mouse Embryo Fibroblasts. Methods Protoc. 2019 Nov 13;2(4). pii: E85.
Korenjak M, Zavadil J. Experimental identification of cancer driver alterations in the era of pan-cancer genomics. Cancer Sci. 2019 Dec;110(12):3622-3629.
Zhivagui M, Ng AWT, Ardin M, Churchwell MI, Pandey M, Renard C, Villar S, Cahais V, Robitaille A, Bouaoun L, Heguy A, Guyton KZ, Stampfer MR, McKay J, Hollstein M, Olivier M, Rozen SG, Beland FA, Korenjak M, Zavadil J. Experimental and pan-cancer genome analyses reveal widespread contribution of acrylamide exposure to carcinogenesis in humans. Genome Res. 2019 Apr;29(4):521-531.
Huskova H, Ardin M, Weninger A, Vargova K, Barrin S, Villar S, Olivier M, Stopka T, Herceg Z, Hollstein M, Zavadil J, Korenjak M. Modeling cancer driver events in vitro using barrier bypass-clonal expansion assays and massively parallel sequencing. Oncogene. 2017 Oct 26;36(43):6041-6048.
Zhivagui M, Korenjak M, Zavadil J. Modelling Mutation Spectra of Human Carcinogens Using Experimental Systems. Basic Clin Pharmacol Toxicol. 2017 Sep;121 Suppl 3:16-22.